These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6321650)

  • 1. The organotypic tissue culture model of corticostriatal system used for examining amino acid neurotoxicity and its antagonism: studies on kainic acid, quinolinic acid and (-) 2-amino-7-phosphonoheptanoic acid.
    Whetsell WO; Schwarcz R
    J Neural Transm Suppl; 1983; 19():53-63. PubMed ID: 6321650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of kainic acid and quinolinic acid toxicity by neostriatal transplants in vitro.
    Whetsell WO; Allen GS; Tulipan NB
    Neurosci Lett; 1989 Jan; 96(1):18-22. PubMed ID: 2522604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system.
    Whetsell WO; Schwarcz R
    Neurosci Lett; 1989 Feb; 97(3):271-5. PubMed ID: 2524015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid.
    Foster AC; Vezzani A; French ED; Schwarcz R
    Neurosci Lett; 1984 Aug; 48(3):273-8. PubMed ID: 6237279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP as a marker of excitotoxin-induced nerve cell death in vivo.
    Vezzani A; Sangalli L; Wu HQ; Schwarcz R
    J Neural Transm; 1987; 70(3-4):349-56. PubMed ID: 2960779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the potential neurotoxic and convulsant effects of increased blood levels of quinolinic acid in rats with altered blood-brain barrier permeability.
    Vezzani A; Stasi MA; Wu HQ; Castiglioni M; Weckermann B; Samanin R
    Exp Neurol; 1989 Oct; 106(1):90-8. PubMed ID: 2551719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxic effects of endogenous materials: quinolinic acid, L-pyroglutamic acid, and thyroid releasing hormone (TRH).
    McGeer EG; Singh E
    Exp Neurol; 1984 Nov; 86(2):410-3. PubMed ID: 6436049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurotoxic actions of quinolinic acid in the central nervous system.
    el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ
    Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons.
    Galarraga E; Surmeier DJ; Kitai ST
    Brain Res; 1990 Apr; 512(2):269-76. PubMed ID: 1972342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of nimodipine against quinolinic acid-induced damage of rat hippocampus in vitro.
    Matyja E; Kida E
    Neuropatol Pol; 1991; 29(1-2):69-77. PubMed ID: 1839931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative toxicity of kainic acid and other acidic amino acids toward rat hippocampal neurons.
    Nadler JV; Evenson DA; Cuthbertson GJ
    Neuroscience; 1981; 6(12):2505-17. PubMed ID: 6275297
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurotoxicity of quinolinate in the rat nucleus basalis magnocellularis.
    Boegman RJ; Metcalf R; Riopelle RJ; Ludwin SK
    Brain Res; 1987 Aug; 417(2):315-20. PubMed ID: 2958107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds.
    Foster AC; Collins JF; Schwarcz R
    Neuropharmacology; 1983 Dec; 22(12A):1331-42. PubMed ID: 6229703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal damage in the albino rat: excitotoxin, microtubule inhibitor synergism.
    Cohen MR; Sridhara N; McElveen TS; Gutman R
    Life Sci; 1988; 43(13):1039-44. PubMed ID: 2971848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal grafts provide sustained protection from kainic and quinolinic acid-induced damage.
    Tulipan N; Luo SQ; Allen GS; Whetsell WO
    Exp Neurol; 1988 Dec; 102(3):325-32. PubMed ID: 2973990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolinic and kainic acids can enhance calcitonin gene-related peptide-like immunoreactivity in striatal neurons with substance P-like immunoreactivity.
    Sugimoto T; Mizuno N
    Brain Res; 1987 Aug; 418(2):392-7. PubMed ID: 2445418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolinate mimics neurotoxic actions of N-methyl-D-aspartate in rat cerebellar slices.
    Garthwaite G; Garthwaite J
    Neurosci Lett; 1987 Aug; 79(1-2):35-9. PubMed ID: 2959887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum.
    Zhu SG; McGeer EG; Singh EA; McGeer PL
    Neurosci Lett; 1988 Dec; 95(1-3):252-6. PubMed ID: 2976129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic effect induced by quinolinic acid in dissociated cell culture of mouse hippocampus.
    Khaspekov L; Kida E; Victorov I; Mossakowski MJ
    J Neurosci Res; 1989 Feb; 22(2):150-7. PubMed ID: 2523487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolinate neurotoxicity in cortical cell culture.
    Kim JP; Choi DW
    Neuroscience; 1987 Nov; 23(2):423-32. PubMed ID: 2963969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.